Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
Cancer Research Communications
|
September 29, 2023
Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment
Jesus Amo-Aparicio, Adrian Dominguez, Shaikh M Atif, et al.
International Journal of Paediatric Dentistry
|
November 24, 2021
Saliva as a reliable sample for COVID-19 diagnosis in paediatric patients
Alvina C Felix, Anderson V de Paula, Andreia C Ribeiro, et al.
BMC Cancer
|
October 30, 2022
ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer
S Lindsey Davis, Sarah J Hartman, Stacey M Bagby, et al.
Cancers
|
April 27, 2024
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, et al.
Plos One
|
April 10, 2024
Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)
Hayley J Hawkins, Betelehem W Yacob, Monica E Brown, et al.
Pathogens (Basel, Switzerland)
|
July 26, 2024
Detection of Multiple Human Viruses, including Mpox, Using a Wastewater Surveillance Approach in Brazil
Juliana Calabria de Araujo, Ana Paula Assad Carvalho, Cintia D Leal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2017
<sup>Non-V600</sup> BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer
Jeremy C Jones, Lindsay A Renfro, Humaid O Al-Shamsi, et al.
Nature Medicine
|
January 9, 2024
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Shubham Pant, Zev A Wainberg, Colin D Weekes, et al.
The Oncologist
|
August 27, 2024
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study
Erkut H Borazanci, Nathan Bahary, Vincent Chung, et al.
Frontiers in Oncology
|
November 24, 2022
Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models
Julie Lang, Alexis D Leal, Juan A Marín-Jiménez, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
Cancer Research Communications
|
September 29, 2023
Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment
Jesus Amo-Aparicio, Adrian Dominguez, Shaikh M Atif, et al.
International Journal of Paediatric Dentistry
|
November 24, 2021
Saliva as a reliable sample for COVID-19 diagnosis in paediatric patients
Alvina C Felix, Anderson V de Paula, Andreia C Ribeiro, et al.
BMC Cancer
|
October 30, 2022
ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer
S Lindsey Davis, Sarah J Hartman, Stacey M Bagby, et al.
Cancers
|
April 27, 2024
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors
S Lindsey Davis, Wells A Messersmith, W Thomas Purcell, et al.
Plos One
|
April 10, 2024
Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)
Hayley J Hawkins, Betelehem W Yacob, Monica E Brown, et al.
Pathogens (Basel, Switzerland)
|
July 26, 2024
Detection of Multiple Human Viruses, including Mpox, Using a Wastewater Surveillance Approach in Brazil
Juliana Calabria de Araujo, Ana Paula Assad Carvalho, Cintia D Leal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2017
<sup>Non-V600</sup> BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer
Jeremy C Jones, Lindsay A Renfro, Humaid O Al-Shamsi, et al.
Nature Medicine
|
January 9, 2024
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Shubham Pant, Zev A Wainberg, Colin D Weekes, et al.
The Oncologist
|
August 27, 2024
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study
Erkut H Borazanci, Nathan Bahary, Vincent Chung, et al.
Frontiers in Oncology
|
November 24, 2022
Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models
Julie Lang, Alexis D Leal, Juan A Marín-Jiménez, et al.
Page
of 8